CORDIS SUCTION RESERVOIR - MODEL NUMBER: 910-500

K963839 · Cordis Corp. · GCY · Dec 12, 1996 · General, Plastic Surgery

Device Facts

Record IDK963839
Device NameCORDIS SUCTION RESERVOIR - MODEL NUMBER: 910-500
ApplicantCordis Corp.
Product CodeGCY · General, Plastic Surgery
Decision DateDec 12, 1996
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 878.4680
Device ClassClass 1
AttributesTherapeutic

Indications for Use

The Cordis Suction Reservoir Kit is intended to be used with the Cordis Subdural Drainage Catheter for drainage of extraventricular fluid collections.

Device Story

Device consists of 100 cc suction reservoir with 25 cc graduated markers and extension tubing with male Luer connector; incorporates anti-reflux valve to prevent backflow. Operates by providing consistent negative pressure as reservoir returns to original shape/volume. Used in clinical settings for post-operative drainage; operated by healthcare professionals. Facilitates collection and measurement of extraventricular fluid.

Clinical Evidence

No clinical data; bench testing only.

Technological Characteristics

100 cc capacity reservoir; graduated markers; anti-reflux valve; extension tubing with male Luer connector. Non-powered, single-patient, portable suction apparatus. Class I device (21 CFR 878.4680).

Indications for Use

Indicated for drainage of extraventricular fluid collections in patients requiring subdural drainage.

Regulatory Classification

Identification

A nonpowered, single patient, portable suction apparatus is a device that consists of a manually operated plastic, disposable evacuation system intended to provide a vacuum for suction drainage of surgical wounds.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0} Cordis Corporation Premarket Notification 510(k) - Cordis Suction Reservoir Kit September 23, 1996 K963839 # ATTACHMENT - 1 ## SUMMARY OF SAFETY AND EFFECTIVENESS a. **Trade (proprietary) Name** Cordis Suction Reservoir Kit DEC 12 1996 b. **Common/Classification Name** Suction reservoir/Nonpowered, single patient, portable suction apparatus. c. **Applicant’s Name and Address** Cordis Corporation 14201 NW 60th Avenue Miami Lakes, FL 33014 d. **Classification** This device is classified as Class I (21 CFR 878.4680). e. **Predicate Devices** Sil-Med Suction Reservoir Cordis Integral Drainage/Ventricular/Lumbar Drainage Sets f. **Performance Standards** No applicable performance standards have been established by FDA under section 514 of the Food, Drug and Cosmetic Act. g. **Intended Use and Device Description** The Cordis Suction Reservoir Kit is intended to be used with the Cordis Subdural Drainage Catheter for drainage of extraventricular fluid collections. The kit consists of a Suction Reservoir and an extension tubing with an integrated male Luer connector. The Suction Reservoir has a 100 cc capacity with graduated markers every 25 cc allowing measurement of fluid collections. It also incorporates an anti-reflux valve to prevent backflow. The Suction Reservoir provides consistent negative pressure while returning to its original shape and volume. {1} Cordis Corporation Premarket Notification 510(k) - Cordis Suction Reservoir Kit September 23, 1996 ## h. Biocompatibility No new issues of biocompatibility are raised. The Suction Reservoir was cleared for a wide variety of applications in post-operative drainage procedures, including neurosurgery applications. The extension line was cleared for a similar application (cerebrospinal fluid drainage, sampling and collection). ## I. Summary of Substantial Equivalence¹: The indications and contraindications of the Cordis Suction Reservoir Kit are included in those of the predicates. The design, materials, manufacturing methods and specifications of the Cordis Suction Reservoir Kit are equivalent to those of the predicate devices and do not raise any new issues relating to safety and effectiveness for its intended use. ¹Any statement made in conjunction with this submission regarding substantial equivalence to any other product only relates to whether the product can be lawfully marketed without premarket approval or reclassification and is not to be interpreted as an admission or used as evidence in patent infringement litigation. As the Commissioner of the FDA has indicated, " . . . a determination of substantial equivalence under the Federal Food, Drug, and Cosmetic Act relates to the fact that the product can lawfully be marketed without premarket approval or reclassification. This determination is not intended to have any bearing whatsoever on the resolution of patent infringement suits." 42 Fed. Reg. 42,520 et seq. (1977).
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...